These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21668397)

  • 1. Biomarkers in chronic graft-versus-host disease.
    Rozmus J; Schultz KR
    Expert Rev Hematol; 2011 Jun; 4(3):329-42. PubMed ID: 21668397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.
    Partanen J; Hyvärinen K; Bickeböller H; Bogunia-Kubik K; Crossland RE; Ivanova M; Perutelli F; Dressel R
    Front Immunol; 2020; 11():575492. PubMed ID: 33193367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation.
    Gao L; Zhang Y; Hu B; Liu J; Kong P; Lou S; Su Y; Yang T; Li H; Liu Y; Zhang C; Gao L; Zhu L; Wen Q; Wang P; Chen X; Zhong J; Zhang X
    J Clin Oncol; 2016 Aug; 34(24):2843-50. PubMed ID: 27400949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications for biomarkers of acute and chronic graft-versus-host disease.
    Levine JE; Paczesny S; Sarantopoulos S
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S116-24. PubMed ID: 22226094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances and research progress in biomarkers for chronic graft versus host disease.
    Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
    Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.
    Crossland RE; Perutelli F; Bogunia-Kubik K; Mooney N; Milutin Gašperov N; Pučić-Baković M; Greinix H; Weber D; Holler E; Pulanić D; Wolff D; Dickinson AM; Inngjerdingen M; Grce M
    Front Immunol; 2020; 11():602547. PubMed ID: 33424849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.
    Ren HG; Adom D; Paczesny S
    Expert Rev Clin Immunol; 2018 May; 14(5):389-404. PubMed ID: 29629613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease.
    Lelas A; Greinix HT; Wolff D; Eissner G; Pavletic SZ; Pulanic D
    Front Immunol; 2021; 12():676756. PubMed ID: 33995421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.
    Nash RA; Storb R
    Curr Opin Immunol; 1996 Oct; 8(5):674-80. PubMed ID: 8902393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice.
    Radojcic V; Paz K; Chung J; Du J; Perkey ET; Flynn R; Ivcevic S; Zaiken M; Friedman A; Yan M; Pletneva MA; Sarantopoulos S; Siebel CW; Blazar BR; Maillard I
    Blood; 2018 Nov; 132(20):2188-2200. PubMed ID: 30181175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Biomarkers for Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kalariya N; Bowe C; Dains JE
    Oncol Nurs Forum; 2020 Mar; 47(2):E35-E43. PubMed ID: 32078615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease.
    Hong C; Jin R; Dai X; Gao X
    Front Immunol; 2021; 12():614183. PubMed ID: 33717098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].
    Chen T; Li XP; Zhang C; Kong PY; Gao QG; Tang L; Wang R; Yang SJ; Gao L; Liu Y; Gao L; Feng YM; Rao J; Peng XG; Zhang X
    Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):948-952. PubMed ID: 31856446
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.
    Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H
    Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.
    Hillhouse EE; Thiant S; Moutuou MM; Lombard-Vadnais F; Parat R; Delisle JS; Ahmad I; Roy DC; Guimond M; Roy J; Lesage S
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):19-25. PubMed ID: 30244108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation.
    Kotani A; Ishikawa T; Matsumura Y; Ichinohe T; Ohno H; Hori T; Uchiyama T
    Blood; 2001 Nov; 98(10):3162-4. PubMed ID: 11698307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.